iRhythm Technologies, Inc.

iRhythm Technologies, Inc. is a digital healthcare company based in San Francisco, California, that specializes in the detection, prediction, and prevention of cardiac arrhythmias. The company combines wearable biosensors with cloud-based data analytics and machine-learning algorithms to provide clinically actionable insights from heart data. Their mission is to enhance health outcomes through earlier and more accurate diagnoses of heart rhythm disorders. The flagship product platform, Zio by iRhythm, includes several integrated solutions such as the Zio Monitor System for continuous ECG monitoring, Zio AT for real-time arrhythmia detection, and ZioSuite, a web portal and mobile app for report interpretation and patient management. The MyZio Patient App allows patients to log symptoms and access educational content. iRhythm's technology is FDA-cleared and has been validated to match the accuracy of expert cardiologists, having served over 8 million patients and analyzed more than 1.5 billion hours of heartbeat data. The company is committed to a patient-centered approach and values integrity, collaboration, and innovation in its operations.

• Employees 2000
• Founded 2006
• Annual Revenue $591839000
• Total Funding $1133250006